Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxytocin and Atosiban effects on top-down attention
NCT07140237Phase 1Recruiting
- Sponsor
- University of Electronic Science and Technology of China
- Start
- Sep 2025
- Primary completion
- Dec 2025
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of oxytocin nasal spray in Autism Spectrum Disorder (ASD) (5 arms), sponsored by University of Electronic Science and Technology of China. Primary endpoints: Error rates in prosaccade and antisaccade trials and Responses latencies for prosaccades and antisaccades. Started Sep 2025; status: recruiting.
02
Drugs
oxytocin nasal spray
03
Conditions
Autism Spectrum Disorder (ASD)
Beyond the preview
Go deeper on NCT07140237.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07140237.